바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.59 No.2
Citation Share

Myeloperoxidase -463G>A Polymorphism dose not Contribute to the Risk of Primary Lung Cancer in a Korean Population

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.2, pp.157-163












& (2005). Myeloperoxidase -463G>A Polymorphism dose not Contribute to the Risk of Primary Lung Cancer in a Korean Population. Tuberculosis & Respiratory Diseases, 59(2), 157-163.
  • Downloaded
  • Viewed
PDF Download

Abstract

목 적 : Myeloperoxidase (MPO)는 benzo(a)pyrene, aromatic amines과 같은 발암전구물질 활성화를 통해 폐암 발생에 관여한다. MPO 유전자 promoter 부위의 -463G>A다형성은 MPO유전자의 발현량을 감소시킨다고 알려져 있다. 저자들은 MPO 유전자 promoter 부위의 -463G>A 다형성과 폐암 위험도의 상관 관계를 조사하였다. 방 법 : 경북대학교병원에서 폐암으로 진단된 432예를 대상으로 하였으며 대조군은 건강검진센타를 방문한 건강인 가운데 환자군과 연령 및 성을 match하여 무작위로 선택한 432명을 대상으로 하였다. 결 과 : MPO -463G>A의 유전자형은 폐암군의 경우 GG, GA, AA형이 각각 353명(81.7%), 76명(17.6%), 3명(0.7%)이였고 대조군의 경우 각각 356명(82.4%), 72명(16.7%), 4명(0.9%)으로 두 군간에 유의한 차이가 없었다. -463 AA+GA 유전자형은 -463 GG 유전자형에 비해 전체 폐암의 경우 위험도의 유의한 차이가 없었으며 (adjusted OR= 1.03, 95% CI= 0.72-1.47), 연령, 성별, 흡연력, 조직형으로 구분하였을 경우에도 유의한 차이가 없었다.결 론 : MPO 유전자의 -463G>A 다형성은 한국인에서 폐암의 위험도를 결정하는 주요 인자가 아닌 것으로 생각된다. (Tuberc Respir Dis 2005; 59: 157-163)

keywords
Myeloperoxidase, Polymorphism, Lung cancer susceptibility, Myeloperoxidase, Polymorphism, Lung cancer susceptibility

Reference

1.

Mallet WG, (carcinogenesis1991) 8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidases,

2.

Piedrafita FJ, (1996) An Alu element in the myeloperoxidase promoter contains a composite SP1- thyroid hormone-retinoic acid response element,

3.

van Schooten FJ, (2004) Myeloperoxidase(MPO)-463G→A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers,

4.

Feyler A, (2002) Myeloperoxidase -463 G → a polymorphism and lung cancer risk,

5.

Xu LL, (2002) The myeloperoxidase -463 G → a polymorphism does not decrease lung cancer susceptibility in Caucasians,

6.

Dally H, (2002) Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 a allele is associated with reduced risk for small cell lung cancer in smokers,

7.

le Marchand l, (2000) Association of the myeloperoxidase -463 G → a polymorphism with lung cancer risk,

8.

Lu W, (2002) Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population,

9.

Lee SJ, (2004) DNMT3B polymorphisms and risk of primary lung cancer,

10.

Lee GY, (2005) XPC polymorphisms and lung cancer risk,

11.

Lee SJ, (2005) Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer,

12.

Lee CT, (2000) Characteristics of lung cancer in Korea,1997,

13.

London SJ, (1997) Myeloperoxidase genetic polymorphism and lung cancer risk,

14.

Hong YC, (2002) Genetic susceptibility to term pregnant women to oxidative damage,

15.

Misra RR, (2001) Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland,

16.

Chevrier I, (2003) Myeloperoxidase:new polymorphisms and relation with lung cancer risk,

17.

Cascorbi I, (2000) Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene,

18.

Schabath MB, (2002) A myeloperoxidase polymorphism associated with reduced risk of lung cancer,

19.

Hamajima N, (2001) Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy